Comparing two versions of an injected medicine in healthy adults
Part of Hormones & metabolism clinical trials.
This trial tests two forms of an injected medication, HUC2-676 and HUC2-676-R, to see how safe they are and how the body processes them. It is for healthy adults who want to help compare these treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 65 years old.
- You are in good general health with no major medical problems.
- You understand the study details and agree to follow all rules.
- If you are a woman, you are not pregnant or nursing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different versions of an injected study drug (survodutide) to see how they are absorbed by the body. It is open to healthy people and people with overweight or obesity, and it may help researchers find a better way to deliver this treatment.
This trial tests a new injection called HS-20136-2. It looks at what happens to the drug in healthy people and in people with obesity. This helps find safe doses and see how the drug works.
This trial tests an investigational drug called GUB-UCN2 in people who are healthy, overweight, or have type 2 diabetes. The goal is to see if the drug is safe and how the body processes it.
This early-phase trial tests the safety and tolerability of a new injection called HRS-5817 in healthy volunteers. It helps researchers understand how the drug moves through the body and what side effects it might have.
This trial tests a new medicine, HM17321, to see how the body processes it. It is for healthy adults and adults with obesity who want to help find new treatment options.
This study tests whether two different formulations of an experimental medication (AJU-C715) work the same way in your body. Researchers will give you one version and then later the other version to compare how much of the drug enters your bloodstream and how long it stays there.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.